FDA issues a safety alert for MediHoney and CVS Wound Gel products due to packaging failures that may compromise sterility ...

Interdisciplinary multimodal pain treatment is associated with modest improvements in quality of life among adults with ...

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...

Ianalumab receives FDA Breakthrough Therapy status for Sjögren disease following positive findings from two phase 3 clinical trial programs.

For adults in the ED with a suspected opioid overdose, bradycardia appears to be associated with increased likelihood of xylazine detection.

Particular diets and diet patterns may be an influence on the risk for developing persistent tinnitus in women, ...

Immediate pain reductions were noted among patients in the ED after receiving acupuncture for acute musculoskeletal pain.

Perioperative factors, such as preoperative cannabis use and discharge dosing levels, are linked to higher opioid refill rates after otolaryngology surgery.

South Carolina and parts of the Southwestern US are facing measles outbreaks as health officials struggle to manage a growing number of cases.

Between 2016 and 2022, privately insured adults in the US used more medications for opioid use disorder following surgical ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2025. The list ...

Instructions for responding to the Patient Health Questionnaire, used to measure severity of depression, are often misinterpreted by patients.